Back
Heron Therapeutics, Inc. 10K Form
Sell
47
HRTX
Heron Therapeutics, Inc.
Last Price:
$1.41
Seasonality Move:
20.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HRTX News And Ratings
See the #1 stock for the next 7 days that we like better than HRTX
HRTX Financial Statistics
Sales & Book Value
| Annual Sales: | $144.3M |
|---|---|
| Cash Flow: | $1.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.04 |
| Price / Book: | 35.77 |
Profitability
| EPS (TTM): | -0.08090 |
|---|---|
| Net Income (TTM): | $-13.6M |
| Gross Margin: | $105.6M |
| Return on Equity: | 0% |
| Return on Assets: | -5.8% |
Heron Therapeutics, Inc. Earnings Forecast
Key Heron Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 38 years for HRTX is 73.21%.
-
The Selling, General & Administrative Expenses for HRTX have been equal to 69.64% of Gross Profit Margin.
-
The Research & Development expenses have been 11.56% of Revenue.
-
The Net Earning history of HRTX is -9.41% of Total Revenues.
-
Per Share Earnings over the last 38 years have been positive in 21 years.
Heron Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | HRTX |
| CUSIP: | 427746 |
| Website: | herontx.com |
Debt
| Debt-to-Equity Ratio: | 9.44 |
|---|---|
| Current Ratio: | 2.56 |
| Quick Ratio: | 1.52 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 112 |
HRTX Technical Analysis vs Fundamental Analysis
Sell
47
Heron Therapeutics, Inc. (HRTX)
is a Sell
Is Heron Therapeutics, Inc. a Buy or a Sell?
-
Heron Therapeutics, Inc. stock is rated a SellThe current Heron Therapeutics, Inc. [HRTX] share price is $1.37. The Score for HRTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.